Prostate News Archive
21-Apr-2009
PROVENGE Significantly Prolongs Survival In Men With Advanced Prostate Cancer In Pivotal Phase 3 IMPACT Study (Medical News Today)
Mary Crowley Cancer Research Centers in Dallas, Texas announced that the pivotal Phase 3 IMPACT study of PROVENGE(R) (sipuleucel-T) in men with advanced prostate cancer met its primary endpoint of improving overall survival compared to a placebo control. Designer T Cells Fight Prostate Cancer (WebMD)
Using gene therapy, researchers have re-educated patients' own immune systems to attack prostate tumors in the body. The bottom line on prostate cancer (C-Health)
One: Benjamin Disraeli, Queen Victoria's prime minister, once remarked "There are three kinds of lies -- lies, damned lies and statistics." Disraeli, if he had been a doctor, could have been referring to the PSA test for prostate cancer. For instance, the New England Journal of Medicine has just reported a European study that showed that this blood test cut the death rate of this disease by 20%. ... Science Makes Inroads Against Prostate, Other Cancers (HealthCentral)
In studies, an immune boost fights prostate tumors, and better drugs outwit brain, pancreatic malignancies.
Back to Prostate News Archive
